Ex-Dezima CEO co-founds NASH startup, flying into Phase IIB with €25 million
A new Dutch biotech, co-founded and led by the former CEO of Dezima, is launching with €25 million in startup capital from prominent European investors …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.